Capstone Investment Advisors, LLC Organon & Co. Call Options Transaction History

Capstone Investment Advisors, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 01, 2024	SELL	$13.78 - $18.8 $53,742 - $73,320	-3,900 Reduced 61.9%	2,400 $45,000
Q4 2023 Feb 12, 2024	BUY	$10.95 - $17.32 $20,805 - $32,908	1,900 Added 43.18%	6,300 $90,000
Q3 2023 Nov 13, 2023	BUY	$16.59 - $23.77 $8,295 - $11,885	500 Added 12.82%	4,400 $76,000
Q1 2023 May 09, 2023	SELL	$21.42 - $32.08 $186,354 - $279,096	-8,700 Reduced 69.05%	3,900 $91,000
Q4 2022 Feb 10, 2023	BUY	$23.31 - $28.61 $4,662 - $5,722	200 Added 1.61%	12,600 $352,000
Q3 2022 Nov 10, 2022	SELL	$23.4 - $34.25 $58,500 - $85,625	-2,500 Reduced 16.78%	12,400 $290,000
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $22,162 - $27,230	-700 Reduced 4.49%	14,900 $503,000
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $389,760 - $503,808	-12,800 Reduced 45.07%	15,600 $545,000
Q4 2021 Feb 11, 2022	BUY	$28.67 - $37.13 $286,700 - $371,300	10,000 Added 54.35%	28,400 $865,000
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $526,792 - $655,776	18,400 New	18,400 $603,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.